Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s ...

Novartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in the US, which accounts for around half its sales. The Swiss pharma group ...

Generic drugs are incredibly important in the medical field, not only for their effectiveness, but also for their cost-saving potential for both manufacturers and customers. Medication affordability ...